세계의 백혈병 치료 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측

■ 영문 제목 : Global Blood Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Globalinforesearch 회사가 출판한 조사자료로, 코드는 GIR-AA1094 입니다.■ 상품코드 : GIR-AA1094
■ 조사/발행회사 : Globalinforesearch
■ 발행일 : 2019년 1월 29일
■ 페이지수 : 122
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,480 ⇒환산₩4,176,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,220 ⇒환산₩6,264,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD6,960 ⇒환산₩8,352,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 백혈병 치료의 세계시장에 대해서 조사분석한 자료로서, 백혈병 치료의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다.
・세계의 백혈병 치료시장동향
・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율)
・주요 지역별 백혈병 치료 시장분석/시장규모
  - 북미시장 (미국, 캐나다, 멕시코)
  - 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아)
  - 아시아시장 (중국, 일본, 한국, 인도, 동남아시아)
  - 남미시장 (브라질, 아르헨티나, 콜롬비아)
  - 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카)
・백혈병 치료의 종류별 시장분석/시장규모
・백혈병 치료의 용도별 시장분석/시장규모
・백혈병 치료의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측)
・백혈병 치료의 판매채널, 유통업체 분석
...
■ 보고서 개요

Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.

Scope of the Report:
The global Blood Cancer Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Cancer Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Blood Cancer Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Cancer Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Novartis
Boehringer Ingelheim
Pfizer
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Chronic Myeloid Leukemia (CML)
Acute Lymphocytic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)

Market Segment by Applications, can be divided into
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics

■ 보고서 목차

Table of Contents

1 Blood Cancer Therapeutics Market Overview
1.1 Product Overview and Scope of Blood Cancer Therapeutics
1.2 Classification of Blood Cancer Therapeutics by Types
1.2.1 Global Blood Cancer Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Blood Cancer Therapeutics Revenue Market Share by Types in 2018
1.2.3 Chronic Myeloid Leukemia (CML)
1.2.4 Acute Lymphocytic Leukemia (ALL)
1.2.5 Chronic Lymphocytic Leukemia (CLL)
1.2.6 Acute Myeloid Leukemia (AML)
1.3 Global Blood Cancer Therapeutics Market by Application
1.3.1 Global Blood Cancer Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.4 Global Blood Cancer Therapeutics Market by Regions
1.4.1 Global Blood Cancer Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Blood Cancer Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Blood Cancer Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Blood Cancer Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Blood Cancer Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Blood Cancer Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Blood Cancer Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Blood Cancer Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Blood Cancer Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Blood Cancer Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Blood Cancer Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Blood Cancer Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Blood Cancer Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Blood Cancer Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Blood Cancer Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Blood Cancer Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Blood Cancer Therapeutics Market Competition, by Players
3.1 Global Blood Cancer Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Blood Cancer Therapeutics Players Market Share
3.2.2 Top 10 Blood Cancer Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Blood Cancer Therapeutics Market Size by Regions
4.1 Global Blood Cancer Therapeutics Revenue and Market Share by Regions
4.2 North America Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Blood Cancer Therapeutics Revenue by Countries
5.1 North America Blood Cancer Therapeutics Revenue by Countries (2014-2019)
5.2 USA Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Blood Cancer Therapeutics Revenue by Countries
6.1 Europe Blood Cancer Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Blood Cancer Therapeutics Revenue by Countries
7.1 Asia-Pacific Blood Cancer Therapeutics Revenue by Countries (2014-2019)
7.2 China Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Blood Cancer Therapeutics Revenue by Countries
8.1 South America Blood Cancer Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Blood Cancer Therapeutics by Countries
9.1 Middle East and Africa Blood Cancer Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Blood Cancer Therapeutics Market Segment by Type
10.1 Global Blood Cancer Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Blood Cancer Therapeutics Market Forecast by Type (2019-2024)
10.3 Chronic Myeloid Leukemia (CML) Revenue Growth Rate (2014-2024)
10.4 Acute Lymphocytic Leukemia (ALL) Revenue Growth Rate (2014-2024)
10.5 Chronic Lymphocytic Leukemia (CLL) Revenue Growth Rate (2014-2024)
10.6 Acute Myeloid Leukemia (AML) Revenue Growth Rate (2014-2024)
11 Global Blood Cancer Therapeutics Market Segment by Application
11.1 Global Blood Cancer Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Blood Cancer Therapeutics Market Forecast by Application (2019-2024)
11.3 Cancer Research Centers Revenue Growth (2014-2019)
11.4 Cancer Hospital Revenue Growth (2014-2019)
11.5 Surgical Centers Revenue Growth (2014-2019)
11.6 Clinics Revenue Growth (2014-2019)
12 Global Blood Cancer Therapeutics Market Size Forecast (2019-2024)
12.1 Global Blood Cancer Therapeutics Market Size Forecast (2019-2024)
12.2 Global Blood Cancer Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Blood Cancer Therapeutics Picture
Table Product Specifications of Blood Cancer Therapeutics
Table Global Blood Cancer Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Blood Cancer Therapeutics Revenue Market Share by Types in 2018
Figure Chronic Myeloid Leukemia (CML) Picture
Figure Acute Lymphocytic Leukemia (ALL) Picture
Figure Chronic Lymphocytic Leukemia (CLL) Picture
Figure Acute Myeloid Leukemia (AML) Picture
Table Global Blood Cancer Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Blood Cancer Therapeutics Revenue Market Share by Applications in 2018
Figure Cancer Research Centers Picture
Figure Cancer Hospital Picture
Figure Surgical Centers Picture
Figure Clinics Picture
Table Global Market Blood Cancer Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Blood Cancer Therapeutics Type and Applications
Table AbbVie Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Blood Cancer Therapeutics Type and Applications
Table AstraZeneca Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Blood Cancer Therapeutics Type and Applications
Table Bristol-Myers Squibb Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Blood Cancer Therapeutics Type and Applications
Table GlaxoSmithKline Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Blood Cancer Therapeutics Type and Applications
Table Roche Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Blood Cancer Therapeutics Type and Applications
Table Novartis Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Blood Cancer Therapeutics Type and Applications
Table Boehringer Ingelheim Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Blood Cancer Therapeutics Type and Applications
Table Pfizer Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Blood Cancer Therapeutics Type and Applications
Table Sanofi Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Blood Cancer Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Blood Cancer Therapeutics Revenue Share by Players (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Share by Players in 2017
Figure Global Blood Cancer Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Blood Cancer Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Blood Cancer Therapeutics Revenue Market Share in 2018
Figure Global Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Blood Cancer Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Blood Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Market Share by Regions in 2018
Figure North America Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Blood Cancer Therapeutics Revenue by Countries (2014-2019)
Table North America Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Blood Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure USA Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Blood Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Blood Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Blood Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Blood Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure China Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Blood Cancer Therapeutics Revenue by Countries (2014-2019)
Table South America Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Blood Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Blood Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Blood Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Blood Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Blood Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Blood Cancer Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Blood Cancer Therapeutics Revenue Share by Type (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Share by Type (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Share by Type in 2019
Table Global Blood Cancer Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Blood Cancer Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Chronic Myeloid Leukemia (CML) Revenue Growth Rate (2014-2019)
Figure Global Acute Lymphocytic Leukemia (ALL) Revenue Growth Rate (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Revenue Growth Rate (2014-2019)
Figure Global Acute Myeloid Leukemia (AML) Revenue Growth Rate (2014-2019)
Table Global Blood Cancer Therapeutics Revenue by Application (2014-2019)
Table Global Blood Cancer Therapeutics Revenue Share by Application (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Share by Application (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue Share by Application in 2019
Table Global Blood Cancer Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Blood Cancer Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Cancer Research Centers Revenue Growth Rate (2014-2019)
Figure Global Cancer Hospital Revenue Growth Rate (2014-2019)
Figure Global Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Blood Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Blood Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Blood Cancer Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Blood Cancer Therapeutics Revenue Market Forecast (2019-2024)
※본 조사보고서 [세계의 백혈병 치료 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측] (코드 : GIR-AA1094) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 백혈병 치료 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요.